Search

everythinglearnresearchcommunity

for

Search:↓

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Keratin 17 is linked to various diseases, including cancer and skin conditions, and may be a target for diagnosis and treatment.

CGF therapy may effectively treat psoriasis by reducing inflammation.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Antioxidants might help with Long Covid by addressing oxidative stress and nutrient imbalances.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Somatostatin may help protect hair follicles from immune attacks.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.

Hair follicle stem cells can help treat ulcerative colitis in mice by releasing beneficial exosomes.